GILD · News · 20261031N
Guidance and Outlook
GILEAD SCIENCES, INC. · 2026-10-31 · Importance 27 · Surprise 32 · In source text
Gilead's full-year 2026 revenue guidance was $31.15 billion at the midpoint. That midpoint was 1.3% above analysts' estimates. The digest provides no further detail on the guidance or the policy headwinds referenced in the article headline.
Key facts
- Gilead Sciences' full-year revenue guidance was $31.15 billion at the midpoint, 1.3% above analysts' estimates. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Gilead Sciences' full-year revenue guidance was $31.15 billion at the midpoint, 1.3% above analysts' estimates. |